Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy President and CEO bought 1,300 shares at $0.51 ($660)
  3. 4 Derivatives Options or other derivatives
  4. 4 Exercise or conversion Chief Scientific Officer acquired 55,120 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 4 Other acquisition 10% owner acquired 1,042,431 shares (other)
  7. 4 Other acquisition 10% owner acquired 700,066 shares (other)
  8. 4 Derivatives Options or other derivatives
  9. 4 Other acquisition 10% owner acquired 261,969 shares (other)
  10. 4 Open-market buy Chief Scientific Officer bought 449 shares at $4.42 ($1,985)
  11. 4 Other acquisition 10% owner acquired 74,240 shares (other)
  12. 4 Other acquisition 10% owner acquired 337,452 shares (other)
  13. 4 Other acquisition 10% owner acquired 176,586 shares (other)
  14. 4 Other acquisition 10% owner acquired 38,851 shares (other)
  15. 4 Exercise or conversion President and CEO acquired 183,347 shares (option exercise)
  16. 4 Open-market buy Director bought 5,100 shares at $1.95 ($9,963)
  17. 4 Open-market buy Director bought 97,410 shares at an average $1.92 ($187,450)
  18. 4 Open-market buy Director bought 147,130 shares at an average $1.76 ($259,356)
  19. 4 Other acquisition 10% owner acquired 67,851 shares (other)
  20. 4 Other acquisition 10% owner acquired 308,412 shares (other)

Page 16 of 34 · 675 filings